Journals / MN Oftalmoloji / 2014 / Cilt: 21 - Sayı: 4

Choroidal thickness measurement with optical coherence tomography in hypertensive patients

Hipertansif hastalarda optik koherans tomografi ile koroid kalınlığı ölçümü

Pages
257–261
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study, we found that the measurement of choroidal thickness is not different in hypertensive patients from healthy individuals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To investigate whether choroidal thickness is different in hypertensive patients from healthy individuals.
📊
Key Findings & Data:Results: The mean ages of patients was 66.52±5.97 (56-79).
💡
Conclusion & Impact:Conclusion: In this study, we found that the measurement of choroidal thickness is not different in hypertensive patients from healthy individuals.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To investigate whether choroidal thickness is different in hypertensive patients from healthy individuals. Material and Metod: In this prospective study, the average choroidal thickness was compared with the control group in hypertensive patients. All the measurement of the choroid was performed in Enhanced Depth Imaging mode with optical coherence tomography. Choroidal thickness was calculated by measuring the distance between the posterior border of retinal pigment epithelium and intersection of choroid-sclera in the horizontal plane. Results: The mean ages of patients was 66.52±5.97 (56-79). There was a 35 female (52.24%) and 32 male (47.76%) patients. Choroidal thickness measurements compared with the control group in hypertensive patients. There was no statistically significant difference between groups (p> 0.05). The patients were regrouped according to the stage of hypertensive retinopathy. There was no statistically difference in mean subfoveal choroidal thickness between these groups. Conclusion: In this study, we found that the measurement of choroidal thickness is not different in hypertensive patients from healthy individuals.

Özet

Amaç: Hipertansif hastalarda koroid kalınlığının sağlıklı bireylerden farklı olup olmadığını araştırmak. Gereç ve Yöntem: Bu prospektif çalışmada, hipertansif hastaların ortalama koroid kalınlıkları kontrol grubuyla karşılaştırıldı. Tüm katılımcıların koroid ölçümü, optik koherans tomografi ile geliştirilmiş derin görüntüleme (Enhanced Depth Imaging) modunda yapıldı. Koroid kalınlığı horizontal düzlemde, retina pigment epitelinin arka sınırı ile koroid-sklera kesişimi arasındaki mesafe ölçülerek hesaplandı. Bulgular: Hastaların yaş ortalaması 66,52±5,97 (56-79) yıldı. 35’i kadın (%52,24), 32’si (%47.76) erkekti. Hipertansif hastaların koroid kalınlık ölçümleri kontrol grubuyla karşılaştırıldığında arada istatiksel önemli bir fark saptanmadı ( p>0.05). Hastalar hipertansif retinopati evresine göre gruplandırıldı ve bu grupların ortalama koroid kalınlıkları karşılaştırıldığında arada istatiksel fark tespit edilmedi ( p>0,05). Sonuç: Bu çalışmada hipertansif hastalarda koroid kalınlığının, sağlıklı bireylerden farklı olmadığı tespit edildi.

🔖

Cite This Article

GÖKTAŞ, S., ÖZÇİMEN, M., SAKARYA, Y., SAKARYA, R., ALPFİDAN, İ., UĞURLU, I. (2014). Choroidal thickness measurement with optical coherence tomography in hypertensive patients. MN Oftalmoloji, Cilt: 21 - Sayı: 4, 257–261. https://ajindex.com/articles/295606

References (16)

  1. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87
  2. Babalık E. Hipertansiyon Patofizyolojisi. Klinik Gelişim 2005; 18:25-32
  3. Wong TY, Mitchell P. Hypertensive retinopathy. The New England Journal of Medicine 2004;351:2310-7
  4. Joseph BW, Rıchard B. Rosen B, Danıel MB. Systemic Hypertension and the Eye. In:Duane JF. Duane's Clinical Ophthalmology. [CDROM]. Lippincott Williams & Wilkins. 2005;Chapter 13
  5. Hayreh SS, Servais G, Virdi PS. Fundus lesions in malignant hypertension: VI. Hypertensive choroidopathy. Ophthalmo- logy 1986;93:1383
  6. Mumcuoglu T, Erdurman C, Durukan AH. Optik Koherens To- mografi Prensipleri ve Uygulamadaki Yenilikler. T Oft Gaz 2008;38:168-75
  7. Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imag- ing spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500
  8. Alm A. Ocular circulation. In: Hart WM, ed. Adler’s Physiology of the Eye. 9th ed. St. Louis, MO: CV Mosby 1992;198-227
  9. Malhotra SK, Gupta R, Sood S, Kaur L, Kochhar S. Bilateral renal artery stenosis presenting as hypertensive retinopathy and choroidopathy. Indian J Ophthalmol 2002;50:221-3
  10. Kishi S, Tso MOM, Hayreh SS: Fundus lesions in malignant hypertension: I. A pathologic study of experimental hyperten- sive choroidopathy. Arch Ophthalmol 1985;103:1189
  11. Esmaeelpour M, Povazay B, Hermann B, Hofer B, Kajic V, Hale SL, et al. Mapping choroidal and retinal thickness varia- tion in type 2 diabetes using three-dimensional 1060-nm op- tical coherence tomography. Invest Ophthalmol Vis Sci 2011; 52:5311-6
  12. Vujosevic S, Martini F, Cavarzeran F, Pilotto E, Midena E. Macular and peripapillary choroidal thickness in diabetic pa- tients. Retina 2012;32:1781-90
  13. Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral- domain optical coherencetomography. Retina 2012;32:563-8
  14. Wei WB, Xu L, Jonas JB et al. Subfoveal choroidal thickness: the Beijing Eye Study. Ophthalmology 2013;120:175-80
  15. Tso MO, Jampol LM. Pathophysiology of hypertensiveretino- pathy. Ophthalmology 1982;89:1132-45
  16. Margolis R, Spaide RF. A pilot study of enhanced depth im- aging optical coherence tomography of the choroid in normal eyes.